X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Natco Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NATCO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
ADCOCK INGRAM
Jun-14
NATCO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs877351-   
Low Rs424253-   
Sales per share (Unadj.) Rs223.4104.4-  
Earnings per share (Unadj.) Rs31.1-26.3-  
Cash flow per share (Unadj.) Rs40.3-21.8-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs219.581.9-  
Shares outstanding (eoy) m33.07168.78-   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.92.9 100.6%   
Avg P/E ratio x20.9-11.5 -182.3%  
P/CF ratio (eoy) x16.1-13.9 -116.5%  
Price / Book Value ratio x3.03.7 80.4%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m21,50450,974 42.2%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m1,1283,199 35.2%   
Avg. sales/employee Rs ThNM4,103.8-  
Avg. wages/employee Rs ThNM745.2-  
Avg. net profit/employee Rs ThNM-1,034.1-  
INCOME DATA
Net Sales Rs m7,38917,618 41.9%  
Other income Rs m167123 135.4%   
Total revenues Rs m7,55617,741 42.6%   
Gross profit Rs m1,793-3,053 -58.7%  
Depreciation Rs m304760 40.0%   
Interest Rs m366477 76.7%   
Profit before tax Rs m1,290-4,167 -31.0%   
Minority Interest Rs m46-12 -398.6%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m309260 118.6%   
Profit after tax Rs m1,027-4,439 -23.1%  
Gross profit margin %24.3-17.3 -140.1%  
Effective tax rate %23.9-6.2 -383.0%   
Net profit margin %13.9-25.2 -55.2%  
BALANCE SHEET DATA
Current assets Rs m3,68112,903 28.5%   
Current liabilities Rs m3,1237,260 43.0%   
Net working cap to sales %7.632.0 23.6%  
Current ratio x1.21.8 66.3%  
Inventory Days Days89111 80.7%  
Debtors Days Days59124 47.3%  
Net fixed assets Rs m7,6857,521 102.2%   
Share capital Rs m33182 404.3%   
"Free" reserves Rs m6,6700-   
Net worth Rs m7,25913,828 52.5%   
Long term debt Rs m9554,859 19.7%   
Total assets Rs m11,95726,122 45.8%  
Interest coverage x4.5-7.7 -58.5%   
Debt to equity ratio x0.10.4 37.4%  
Sales to assets ratio x0.60.7 91.6%   
Return on assets %11.7-15.2 -76.8%  
Return on equity %14.2-32.1 -44.1%  
Return on capital %20.7-19.8 -104.6%  
Exports to sales %39.40-   
Imports to sales %5.70-   
Net fx Rs m2,7430-   
CASH FLOW
From Operations Rs m1,4401,504 95.8%  
From Investments Rs m-1,089-462 235.9%  
From Financial Activity Rs m-3534,410 -8.0%  
Net Cashflow Rs m-15,452 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.84 Rs / ZAR

Compare NATCO PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare NATCO PHARMA With: CADILA HEALTHCARE  WYETH LTD  STERLING BIOTECH  ALEMBIC LTD  ELDER PHARMA  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 23, 2017 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 8-QTR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS